Net Margin: curis.com (CRIS)

Graphic logo of Curis (CRIS)

Curis, Inc. relies on automated compound screening while outsourcing all stages of clinical trials to external CRO networks. The consolidated net sales margin illustrates the result of this structure, where -1893.20 shows the level of this metric. Current momentum is supported by the success of emavasertib in leukemia therapy, the attainment of FDA statuses, and the potential for acquisition by major pharma behemoths.

CRIS: curis.com Net Profit Rate 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for curis.com (CRIS)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
Basic company analysis:Curis, CRIS
Manufactured product of Curis, Inc.

Curis, Inc. focuses on intensive clinical trials of targeted oncology drugs. The operating net margin demonstrates the share of profit remaining with the company after deducting all expenses from revenue. This calculation allows for an assessment of the efficiency of intellectual capital monetization. The operating net margin trend reflects the balance between R&D costs and income. It is critical for investors to correlate this metric with the regulatory approval stages of the assets.

Competitors of Curis, Inc. (CRIS)

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|APLM: Net Return on Sales|Tharimmune Corporation - Net Sales Margin|ADVB: Net Margin|GNPX: Net Sales Margin|CLDI (Calidi Biotherapeutics Inc.) - Net Margin|Net Margin Sunshine Biopharma, Inc.|Net Sales Margin xeneticbio.com|Net Margin Salarius (SLRX)|Return on Sales by Net Profit Purple Biotech PPBT|Net Margin American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Net Margin|Checkpoint Therapeutics Inc. - Net Sales Margin|Net Profit Rate ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Return on Sales by Net Profit|Ikena Oncology, Inc. - Net Profit Rate|Return on Sales by Net Profit NTBL|VIRX: Net Profit Rate|Net Margin MorphoSys Corporation (MOR)|NAYA - Net Margin|Net Sales Margin AAPGV (Ascentage)